-
Are You Regularly Checking in on Your Relapsing Multiple Sclerosis (RMS) Treatment Journey? [Sponsored Post]
Sponsored ContentINDICATION AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include ... Read more -
5 Things To Know About This Relapsing Multiple Sclerosis (MS) Treatment That Comes In A Pill Sponsored Post
Sponsored Contentgoogletag.cmd.push(function() { googletag.display('div-gpt-ad-1487950311468-5'); }); ... Read more -
#MSVirtual2020 – Masitinib Delays Disability Progression in PPMS, Non-active SPMS
NewsAB Science’s lead candidate masitinib safely and effectively delays disability progression in people with primary progressive multiple sclerosis (PPMS) and ... Read more -
#MSVirtual2020 – Early Use of Ocrevus Slows Thalamic Atrophy in Relapsing MS and PPMS
NewsEarly use of Ocrevus (ocrelizumab) significantly slows shrinkage of the thalamus — a brain region involved in ... Read more -
#MSVirtual2020 – 13-year Data Find Tecfidera Safe, Reduces RRMS Relapses
NewsLong-term treatment with Tecfidera (dimethyl fumarate) continues to be safe and effective at reducing the frequency of relapses ... Read more -
#MSVirtual2020 – Long-term Aubagio Use Seen to Lower Relapse Risk for Children
NewsContinuous treatment with Aubagio (teriflunomide) can safely lower the risk of relapses and disability progression in children with ... Read more -
#MSVirtual2020 – Cognitive Problems in Children With MS Can Persist Into Adulthood
NewsCognitive problems can persist into adulthood in people whose multiple sclerosis (MS) began in childhood or adolescence, and are ... Read more -
#MSVirtual2020 – Pediatric MS Patients May Do Best on Intravenous DMTs, Study Finds
NewsMost children and adolescents with pediatric-onset multiple sclerosis (POMS), especially those treated intravenously with a disease-modifying therapy (DMT), achieve no ... Read more -
#MSVirtual2020 – High-efficacy DMTs More Effective at Slowing Retina Atrophy in RRMS Patients, Study Finds
NewsCompared to low-efficacy disease-modifying therapies (DMTs), high-efficacy medications are more effective at slowing the loss of nerve cells making up ... Read more -
The Surprising Reasons You Might Be Bloated
Columns, DISabled to ENabled – a Column by Jessie AceMany people with multiple sclerosis (MS) struggle with intestinal issues. There is evidence of the link between gut health ... Read more -
#MSVirtual2020 – Remyelination Mainly Conducted by Pre-existing Myelin-producing Cells, Study Finds
NewsRemyelination — or the restoration of lost myelin, the protective sheath surrounding nerve cell fibers — in multiple sclerosis ... Read more -
#MSVirtual2020 – Lesions First Seen on Nerves of GI Tract in Mouse Model of MS
NewsBefore signs of neurodegeneration in the brain and spinal cord are evident in mice with experimental autoimmune encephalomyelitis (EAE) ... Read more -
#MSVirtual2020 – Relapses During Pregnancy More Likely on Higher Efficacy DMTs
NewsWomen with relapsing-remitting multiple sclerosis (RRMS) using moderate- or high-efficacy disease-modifying therapies (DMTs) before conceiving are more likely to ... Read more -
#MSVirtual2020 – Long DMT Exposure May Delay Disability Progression, Wheelchair Use
NewsLonger exposure to disease-modifying therapies (DMTs) may delay disability progression and the time until people with primary progressive multiple ... Read more
What can we help you find today?
![Are You Regularly Checking in on Your Relapsing Multiple Sclerosis (RMS) Treatment Journey? <span>[Sponsored Post]</span>](https://multiplesclerosisnewstoday.com/wp-content/uploads/2020/09/Photo-for-Article-1-470x295.jpg)
